Artificial Sunlight and the Future of Phototherapy: What John MacMahon of CytoKind Wants Patients to Know

Rare Care, the Rare Disease Advisor podcast hosted by Larry Luxner, recently featured an interview with John MacMahon of CytoKind about ultraviolet B light (UVB) and its possible role in helping people with inflammatory and rare diseases.

In this interview, you’ll learn how artificial sunlight — UVB light therapy — works, why it is being studied, and what it may mean for the future of care.

The interview also explains how CytoKind is exploring light-based treatment for immune-related conditions. It gives a clear look at a new area of medicine that may one day offer more options for people living with difficult chronic illnesses.

Listen to the interview here.